You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Monoamine Oxidase Inhibitors

Showing 1 - 25 of 4,464
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD, Treatment Resistant Depression Trial in Toronto ([11C]SL25.1188 PET radiotracer)

Recruiting
  • Major Depressive Disorder
  • Treatment Resistant Depression
  • [11C]SL25.1188 PET radiotracer
  • Toronto, Ontario, Canada
    CAMH
Mar 31, 2022

Structural and Functional Connectivity of Brainstem Monoamine

Completed
  • Treatment Resistant Depression
  • Monoamine Oxidase Inhibitor (MAOI)
  • Cleveland, Ohio
    Cleveland Clinic
Jun 15, 2021

Monoamine Oxidase Inhibitor on Phenotype of Blood Mononucleated

Recruiting
  • SARS-CoV2 Infection
  • blood sample
  • Le Kremlin-Bicêtre, France
    CHU Bicêtre
Dec 20, 2021

Falls in Older Adults: Analysis of World Health Organization

Completed
  • Antidepressants Causing Adverse Effects in Therapeutic Use
  • Fall
  • Antidepressive Agents
  • Caen, Normandie, France
    Caen University Hospital, Department of Pharmacology
Nov 24, 2022

Major Depression, Post Traumatic Stress Disorder Trial in Seattle (SM-001)

Not yet recruiting
  • Major Depression
  • Post Traumatic Stress Disorder
  • Seattle, Washington
    AIMS Institute
Jun 13, 2023

Prescription of Antidepressants and Delirium in Elderly :

Active, not recruiting
  • Antidepressive Agents
  • +2 more
  • Caen, Normandie, France
    Caen University Hospital, Department of Pharmacology
Apr 29, 2022

Healthy Trial in Harrow (BI 1467335)

Completed
Has Results
  • Healthy
  • BI 1467335
  • Harrow, United Kingdom
    Northwick Park Hospital
Jun 11, 2021

Cognitive Performance, Memory, Mood Trial in Gainesville (Muscadine Wine, Muscadine Juice, Vodka)

Not yet recruiting
  • Cognitive Performance
  • +3 more
  • Muscadine Wine
  • +3 more
  • Gainesville, Florida
    Food Science and human nutrition department at University of Flo
Sep 12, 2022

The Antidepressant Advisor: fMRI Study to Predict Treatment

Completed
  • Major Depressive Disorder
    • London, United Kingdom
      King's College London, IoPPN
    Jan 4, 2023

    MDD Trial in Bhubaneswar (Selective Serotonin Reuptake Inhibitors, Dextromethorphan, Placebo)

    Recruiting
    • Major Depressive Disorder
    • Selective Serotonin Reuptake Inhibitors
    • +2 more
    • Bhubaneswar, Odisha, India
      All India Institute of Medical Sciences (AIIMS)
    Feb 11, 2022

    Parkinson Disease, Cerebrospinal Fluid Trial run by the NINDS (drug, procedure, radiation)

    Terminated
    Has Results
    • Parkinson Disease
    • Cerebrospinal Fluid
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Nov 1, 2021

    VYVANSE® in Australia for Binge Eating Disorder

    Completed
    • Binge-eating Disorder
      • Sydney, New South Wales, Australia
        Site
      Nov 19, 2021

      MDD Trial in Toronto (Humalog, Saline nasal spray)

      Recruiting
      • Major Depressive Disorder
      • Toronto, Ontario, Canada
        Centre for Addiction and Mental Health
      Oct 5, 2022

      Associated Burden of Related Conditions in Alopecia Areata

      Completed
      • Alopecia Areata
      • +35 more
      • Exposure of interest (studies 2 & 3).
      • London, United Kingdom
        Momentum Data Ltd
      Dec 13, 2022

      Healthy Trial in Basel (Dimethyltryptamine (DMT), Saline)

      Completed
      • Healthy
      • Basel, Basel-Stadt BS, Switzerland
        University Hospital Basel
      Oct 10, 2022

      Depressive Disorder Trial in Utrecht (Rivastigmine Transdermal Product, Sham)

      Recruiting
      • Depressive Disorder
      • Rivastigmine Transdermal Product
      • Sham
      • Utrecht, Netherlands
        UMC Utrecht
      Mar 2, 2023

      Non-Alcoholic Fatty Liver Disease, Hyperuricemia Trial (Allopurinol (100 mg/day) plus lifestyle intervention, Febuxostat 40 mg

      Not yet recruiting
      • Non-Alcoholic Fatty Liver Disease
      • Hyperuricemia
      • Allopurinol (100 mg/day) plus lifestyle intervention
      • +2 more
      • (no location specified)
      Jul 23, 2022

      Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Beverly Hills, Los Angeles, Pasadena

      Active, not recruiting
      • Adenocarcinoma of the Prostate
      • +5 more
      • phenelzine sulfate
      • +2 more
      • Beverly Hills, California
      • +3 more
      Aug 19, 2022

      Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)

      Enrolling by invitation
      • Parkinson Disease
      • Treatment Adherence
      • Ankara, Turkey
        Ankara Atatürk Sanatorium Training and Research Hospital
      Oct 30, 2023

      Parkinson Disease Trial (Conventional medication, Chinese herbal medicine treatment)

      Not yet recruiting
      • Parkinson Disease
      • Conventional medication
      • Chinese herbal medicine treatment
      • (no location specified)
      Aug 10, 2021

      Depression Trial in Karachi (chamomile tea n saffron)

      Active, not recruiting
      • Depression
      • chamomile tea n saffron
      • Karachi, PK, Pakistan
        Aga Khan University
      Nov 16, 2022

      ECT on Monoamine Oxidase A in Depression Investigated With PET

      Completed
      • Major Depression
      • Electroconvulsive therapy
      • +2 more
      • Vienna, Austria
        Department of Psychiatry and Psychotherapy
      Aug 24, 2019

      Parkinson Disease, Depressive Symptoms, Anxiety Trial in Stavanger (Online cognitive behavioral therapy)

      Recruiting
      • Parkinson Disease
      • +2 more
      • Online cognitive behavioral therapy
      • Stavanger, Norway
        Stavanger University Hospital, Norwegian Centre for Movement Dis
      Jan 2, 2023

      Obesity, Endothelial Dysfunction Trial in Tallahassee (Exercise)

      Recruiting
      • Obesity
      • Endothelial Dysfunction
      • Exercise
      • Tallahassee, Florida
        Florida State University
      Jun 10, 2022

      MDD Trial in Toronto (Sertraline, Citalopram, N-acetylcysteine (NAC))

      Completed
      • Major Depressive Disorder
      • Toronto, Ontario, Canada
        Research Imaging Centre, Centre for Addiction and Mental Health
      May 22, 2019